May , 2011
Ranibizumab (Lucentis) and Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration published by The New England Journal of Medicine April 28, 2011 by the Trials (CATT) research group. Read More
March , 2011
This study looked prospectively at 38,022 women who did not have age-related macular degeneration (AMD) at baseline. In ten years 235 cases of AMD developed. Read More
|
Need Immediate Attention?We are available 24 hours a day / 7 days a week. Call us at: |
